237 related articles for article (PubMed ID: 18952053)
1. Cell fusion in osteoclasts plays a critical role in controlling bone mass and osteoblastic activity.
Iwasaki R; Ninomiya K; Miyamoto K; Suzuki T; Sato Y; Kawana H; Nakagawa T; Suda T; Miyamoto T
Biochem Biophys Res Commun; 2008 Dec; 377(3):899-904. PubMed ID: 18952053
[TBL] [Abstract][Full Text] [Related]
2. DC-STAMP is essential for cell-cell fusion in osteoclasts and foreign body giant cells.
Yagi M; Miyamoto T; Sawatani Y; Iwamoto K; Hosogane N; Fujita N; Morita K; Ninomiya K; Suzuki T; Miyamoto K; Oike Y; Takeya M; Toyama Y; Suda T
J Exp Med; 2005 Aug; 202(3):345-51. PubMed ID: 16061724
[TBL] [Abstract][Full Text] [Related]
3. v-ATPase V0 subunit d2-deficient mice exhibit impaired osteoclast fusion and increased bone formation.
Lee SH; Rho J; Jeong D; Sul JY; Kim T; Kim N; Kang JS; Miyamoto T; Suda T; Lee SK; Pignolo RJ; Koczon-Jaremko B; Lorenzo J; Choi Y
Nat Med; 2006 Dec; 12(12):1403-9. PubMed ID: 17128270
[TBL] [Abstract][Full Text] [Related]
4. GM-CSF regulates fusion of mononuclear osteoclasts into bone-resorbing osteoclasts by activating the Ras/ERK pathway.
Lee MS; Kim HS; Yeon JT; Choi SW; Chun CH; Kwak HB; Oh J
J Immunol; 2009 Sep; 183(5):3390-9. PubMed ID: 19641137
[TBL] [Abstract][Full Text] [Related]
5. MCP-1 expressed by osteoclasts stimulates osteoclastogenesis in an autocrine/paracrine manner.
Miyamoto K; Ninomiya K; Sonoda KH; Miyauchi Y; Hoshi H; Iwasaki R; Miyamoto H; Yoshida S; Sato Y; Morioka H; Chiba K; Egashira K; Suda T; Toyama Y; Miyamoto T
Biochem Biophys Res Commun; 2009 Jun; 383(3):373-7. PubMed ID: 19364494
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms by which cells of the osteoblast lineage control osteoclast formation and activity.
Martin TJ; Ng KW
J Cell Biochem; 1994 Nov; 56(3):357-66. PubMed ID: 7876329
[TBL] [Abstract][Full Text] [Related]
7. Short-term mechanical stress inhibits osteoclastogenesis via suppression of DC-STAMP in RAW264.7 cells.
Kameyama S; Yoshimura Y; Kameyama T; Kikuiri T; Matsuno M; Deyama Y; Suzuki K; Iida J
Int J Mol Med; 2013 Feb; 31(2):292-8. PubMed ID: 23292096
[TBL] [Abstract][Full Text] [Related]
8. NFATc1 induces osteoclast fusion via up-regulation of Atp6v0d2 and the dendritic cell-specific transmembrane protein (DC-STAMP).
Kim K; Lee SH; Ha Kim J; Choi Y; Kim N
Mol Endocrinol; 2008 Jan; 22(1):176-85. PubMed ID: 17885208
[TBL] [Abstract][Full Text] [Related]
9. Tal1 regulates osteoclast differentiation through suppression of the master regulator of cell fusion DC-STAMP.
Courtial N; Smink JJ; Kuvardina ON; Leutz A; Göthert JR; Lausen J
FASEB J; 2012 Feb; 26(2):523-32. PubMed ID: 21990371
[TBL] [Abstract][Full Text] [Related]
10. Pin1 regulates osteoclast fusion through suppression of the master regulator of cell fusion DC-STAMP.
Islam R; Bae HS; Yoon WJ; Woo KM; Baek JH; Kim HH; Uchida T; Ryoo HM
J Cell Physiol; 2014 Dec; 229(12):2166-74. PubMed ID: 24891219
[TBL] [Abstract][Full Text] [Related]
11. The dendritic cell-specific transmembrane protein DC-STAMP is essential for osteoclast fusion and osteoclast bone-resorbing activity.
Miyamoto T
Mod Rheumatol; 2006; 16(6):341-2. PubMed ID: 17164993
[TBL] [Abstract][Full Text] [Related]
12. Osteoblast-specific Angiopoietin 1 overexpression increases bone mass.
Suzuki T; Miyamoto T; Fujita N; Ninomiya K; Iwasaki R; Toyama Y; Suda T
Biochem Biophys Res Commun; 2007 Nov; 362(4):1019-25. PubMed ID: 17825261
[TBL] [Abstract][Full Text] [Related]
13. Osteoblast-targeted expression of Sfrp4 in mice results in low bone mass.
Nakanishi R; Akiyama H; Kimura H; Otsuki B; Shimizu M; Tsuboyama T; Nakamura T
J Bone Miner Res; 2008 Feb; 23(2):271-7. PubMed ID: 17907918
[TBL] [Abstract][Full Text] [Related]
14. Osteoblastic molecular scaffold Gab1 is required for maintaining bone homeostasis.
Weng T; Mao F; Wang Y; Sun Q; Li R; Yang G; Zhang X; Luo J; Feng GS; Yang X
J Cell Sci; 2010 Mar; 123(Pt 5):682-9. PubMed ID: 20124419
[TBL] [Abstract][Full Text] [Related]
15. Are nonresorbing osteoclasts sources of bone anabolic activity?
Karsdal MA; Martin TJ; Bollerslev J; Christiansen C; Henriksen K
J Bone Miner Res; 2007 Apr; 22(4):487-94. PubMed ID: 17227224
[TBL] [Abstract][Full Text] [Related]
16. Impaired bone formation in transgenic mice resulting from altered integrin function in osteoblasts.
Zimmerman D; Jin F; Leboy P; Hardy S; Damsky C
Dev Biol; 2000 Apr; 220(1):2-15. PubMed ID: 10720426
[TBL] [Abstract][Full Text] [Related]
17. Osteoclast stimulatory transmembrane protein and dendritic cell–specific transmembrane protein cooperatively modulate cell–cell fusion to form osteoclasts and foreign body giant cells.
Miyamoto H; Suzuki T; Miyauchi Y; Iwasaki R; Kobayashi T; Sato Y; Miyamoto K; Hoshi H; Hashimoto K; Yoshida S; Hao W; Mori T; Kanagawa H; Katsuyama E; Fujie A; Morioka H; Matsumoto M; Chiba K; Takeya M; Toyama Y; Miyamoto T
J Bone Miner Res; 2012 Jun; 27(6):1289-97. PubMed ID: 22337159
[TBL] [Abstract][Full Text] [Related]
18. Osteoclast-osteoblast communication.
Matsuo K; Irie N
Arch Biochem Biophys; 2008 May; 473(2):201-9. PubMed ID: 18406338
[TBL] [Abstract][Full Text] [Related]
19. The role of DC-STAMP in maintenance of immune tolerance through regulation of dendritic cell function.
Sawatani Y; Miyamoto T; Nagai S; Maruya M; Imai J; Miyamoto K; Fujita N; Ninomiya K; Suzuki T; Iwasaki R; Toyama Y; Shinohara M; Koyasu S; Suda T
Int Immunol; 2008 Oct; 20(10):1259-68. PubMed ID: 18653699
[TBL] [Abstract][Full Text] [Related]
20. Osteoclast polarization is not required for degradation of bone matrix in rachitic FGF23 transgenic mice.
Hollberg K; Marsell R; Norgård M; Larsson T; Jonsson KB; Andersson G
Bone; 2008 Jun; 42(6):1111-21. PubMed ID: 18346951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
